<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> levels before transplantation in children receiving T cell-depleted unrelated grafts for relapsed ALL were associated with a 100% relapse risk </plain></SENT>
<SENT sid="1" pm="."><plain>We report on two children with relapsed ALL who underwent non T cell-depleted BMT from unrelated donors </plain></SENT>
<SENT sid="2" pm="."><plain>Despite a high <z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">residual tumor</z:e> load pre- transplant and the occurrence of only aGVHD grade I, they are still in second complete remission 2.7 and 5.2 years after transplantation, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, we propose that the transplant regimens influence the prognostic significance of high <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> levels pre-BMT </plain></SENT>
</text></document>